带有药品信息附件的电子邮件对处方药销售的影响:一项随机对照研究。

Christina Edward, Anders Himmelmann, Susanna M Wallerstedt
{"title":"带有药品信息附件的电子邮件对处方药销售的影响:一项随机对照研究。","authors":"Christina Edward,&nbsp;Anders Himmelmann,&nbsp;Susanna M Wallerstedt","doi":"10.1186/1472-6904-7-12","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To provide doctors with producer-independent information to facilitate choice of treatment is an important task. The objective of the present study was to evaluate if an e-mail with a drug information attachment has effects on sales of prescribed drugs and if the design of the attachment is of importance.</p><p><strong>Methods: </strong>The Swedish pharmaceutical benefit board found rizatriptan (Maxalt) 10 mg to be the most cost-effective triptan. All 119 heads of primary care units in western Sweden were randomized to receive information concerning this conclusion via (i) e-mail with attachment I, (ii) e-mail with attachment II or (iii) no information (control). Attachment I was a short one (heading plus three lines text), whereas attachment II was a long one (heading plus one page text and one page with tables). The change in percentage rizatriptan of total triptans sold before and after the intervention (May - July 2004 and May - July 2005, respectively) was compared between the groups.</p><p><strong>Results: </strong>Totally 48,229 (2004) and 50,674 (2005) defined daily doses of triptans were prescribed and sold during May - July in primary care units in the western part of Sweden. The absolute change in percentage rizatriptan was greater in the intervention groups compared with the control group 2 (25th - 75th percentile: -3 - 7) vs 0 (-7 - 5), P = 0.031). The absolute change in percentage rizatriptan did not differ between the two attachment groups (P = 0.93).</p><p><strong>Conclusion: </strong>An e-mail with a drug information attachment may influence sales of prescribed drugs. No difference between different designs of the attachment could be detected.</p>","PeriodicalId":9196,"journal":{"name":"BMC Clinical Pharmacology","volume":"7 ","pages":"12"},"PeriodicalIF":0.0000,"publicationDate":"2007-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1472-6904-7-12","citationCount":"7","resultStr":"{\"title\":\"Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.\",\"authors\":\"Christina Edward,&nbsp;Anders Himmelmann,&nbsp;Susanna M Wallerstedt\",\"doi\":\"10.1186/1472-6904-7-12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To provide doctors with producer-independent information to facilitate choice of treatment is an important task. The objective of the present study was to evaluate if an e-mail with a drug information attachment has effects on sales of prescribed drugs and if the design of the attachment is of importance.</p><p><strong>Methods: </strong>The Swedish pharmaceutical benefit board found rizatriptan (Maxalt) 10 mg to be the most cost-effective triptan. All 119 heads of primary care units in western Sweden were randomized to receive information concerning this conclusion via (i) e-mail with attachment I, (ii) e-mail with attachment II or (iii) no information (control). Attachment I was a short one (heading plus three lines text), whereas attachment II was a long one (heading plus one page text and one page with tables). The change in percentage rizatriptan of total triptans sold before and after the intervention (May - July 2004 and May - July 2005, respectively) was compared between the groups.</p><p><strong>Results: </strong>Totally 48,229 (2004) and 50,674 (2005) defined daily doses of triptans were prescribed and sold during May - July in primary care units in the western part of Sweden. The absolute change in percentage rizatriptan was greater in the intervention groups compared with the control group 2 (25th - 75th percentile: -3 - 7) vs 0 (-7 - 5), P = 0.031). The absolute change in percentage rizatriptan did not differ between the two attachment groups (P = 0.93).</p><p><strong>Conclusion: </strong>An e-mail with a drug information attachment may influence sales of prescribed drugs. No difference between different designs of the attachment could be detected.</p>\",\"PeriodicalId\":9196,\"journal\":{\"name\":\"BMC Clinical Pharmacology\",\"volume\":\"7 \",\"pages\":\"12\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/1472-6904-7-12\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Clinical Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/1472-6904-7-12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1472-6904-7-12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

摘要

背景:为医生提供与生产者无关的信息,以促进治疗选择是一项重要任务。本研究的目的是评估带有药物信息附件的电子邮件是否对处方药的销售有影响,以及附件的设计是否重要。方法:瑞典药品利益委员会发现10mg利扎曲坦(Maxalt)是最具成本效益的曲坦类药物。瑞典西部所有119名初级保健单位的负责人被随机分配,通过(i)带有附件i的电子邮件,(ii)带有附件ii的电子邮件或(iii)没有信息(对照)接收有关这一结论的信息。附件1很短(标题加上三行文字),而附件2很长(标题加上一页文字和一页表格)。比较干预前后(分别为2004年5月至7月和2005年5月至7月)利扎曲坦在曲坦类药物总销量中所占百分比的变化。结果:在瑞典西部的初级保健单位,5月至7月期间共开出和销售了48,229(2004年)和50,674(2005年)每日规定剂量的曲坦类药物。干预组的利扎曲坦百分比绝对变化大于对照组2(25 - 75百分位数:-3 -7)vs 0 (-7 - 5), P = 0.031)。利扎曲坦百分比的绝对变化在两组之间没有差异(P = 0.93)。结论:带有药品信息附件的电子邮件可能会影响处方药的销售。不同设计的附件之间没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.

Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.

Background: To provide doctors with producer-independent information to facilitate choice of treatment is an important task. The objective of the present study was to evaluate if an e-mail with a drug information attachment has effects on sales of prescribed drugs and if the design of the attachment is of importance.

Methods: The Swedish pharmaceutical benefit board found rizatriptan (Maxalt) 10 mg to be the most cost-effective triptan. All 119 heads of primary care units in western Sweden were randomized to receive information concerning this conclusion via (i) e-mail with attachment I, (ii) e-mail with attachment II or (iii) no information (control). Attachment I was a short one (heading plus three lines text), whereas attachment II was a long one (heading plus one page text and one page with tables). The change in percentage rizatriptan of total triptans sold before and after the intervention (May - July 2004 and May - July 2005, respectively) was compared between the groups.

Results: Totally 48,229 (2004) and 50,674 (2005) defined daily doses of triptans were prescribed and sold during May - July in primary care units in the western part of Sweden. The absolute change in percentage rizatriptan was greater in the intervention groups compared with the control group 2 (25th - 75th percentile: -3 - 7) vs 0 (-7 - 5), P = 0.031). The absolute change in percentage rizatriptan did not differ between the two attachment groups (P = 0.93).

Conclusion: An e-mail with a drug information attachment may influence sales of prescribed drugs. No difference between different designs of the attachment could be detected.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信